Your browser doesn't support javascript.
loading
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
Borie, Raphael; Savale, Laurent; Dossier, Antoine; Ghosn, Jade; Taillé, Camille; Visseaux, Benoit; Jebreen, Kamel; Diallo, Abourahmane; Tesmoingt, Chloe; Morer, Lise; Goletto, Tiphaine; Faucher, Nathalie; Hajouji, Linda; Neukirch, Catherine; Phillips, Mathilde; Stelianides, Sandrine; Bouadma, Lila; Brosseau, Solenn; Ottaviani, Sébastien; Pluvy, Johan; Le Pluart, Diane; Debray, Marie-Pierre; Raynaud-Simon, Agathe; Descamps, Diane; Khalil, Antoine; Timsit, Jean Francois; Lescure, Francois-Xavier; Descamps, Vincent; Papo, Thomas; Humbert, Marc; Crestani, Bruno; Dieude, Philippe; Vicaut, Eric; Zalcman, Gérard.
Afiliação
  • Borie R; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Savale L; Pulmonology Department, Kremlin-Bicêtre University Hospital, AP-HP, Paris-Saclay University, Kremlin-Bicêtre, France.
  • Dossier A; Internal Medicine Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Ghosn J; Infectious Disease Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Taillé C; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Visseaux B; Virology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Jebreen K; Biostatistics and Clinical Research Department, University Hospital Lariboisière, AP-HP, Université de Paris, Paris, France.
  • Diallo A; Biostatistics and Clinical Research Department, University Hospital Lariboisière, AP-HP, Université de Paris, Paris, France.
  • Tesmoingt C; Pharmacy Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Morer L; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Goletto T; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Faucher N; Geriatrics Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Hajouji L; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Neukirch C; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Phillips M; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Stelianides S; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Bouadma L; Medical and infectious Diseases ICU, Intensive Care Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Brosseau S; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Ottaviani S; Rheumatology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Pluvy J; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Le Pluart D; Infectious Disease Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Debray MP; Radiology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Raynaud-Simon A; Pharmacy Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Descamps D; Virology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Khalil A; Radiology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Timsit JF; Medical and infectious Diseases ICU, Intensive Care Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Lescure FX; Infectious Disease Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Descamps V; Dermatology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Papo T; Internal Medicine Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Humbert M; Pulmonology Department, Kremlin-Bicêtre University Hospital, AP-HP, Paris-Saclay University, Kremlin-Bicêtre, France.
  • Crestani B; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Dieude P; Rheumatology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
  • Vicaut E; Biostatistics and Clinical Research Department, University Hospital Lariboisière, AP-HP, Université de Paris, Paris, France.
  • Zalcman G; Pulmonology and Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
PLoS One ; 15(12): e0243961, 2020.
Article em En | MEDLINE | ID: mdl-33326457
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metilprednisolona / Proteína Antagonista do Receptor de Interleucina 1 / Tratamento Farmacológico da COVID-19 / Glucocorticoides Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metilprednisolona / Proteína Antagonista do Receptor de Interleucina 1 / Tratamento Farmacológico da COVID-19 / Glucocorticoides Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos